Copeptin Serum Level in Liver Transplant Recipients

NCT03587623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2020-08-19

No results posted yet for this study

Summary

The study aim is to measure perioperative copeptin concentration in blood of liver transplant recipients and to assess whether there is a correlation between its level and hemodynamic derangement.

Conditions

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-04
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587623 on ClinicalTrials.gov